Bold Care, cofounded by actor Ranveer Singh, has launched Bloom, a new brand targeting women's wellness across various life stages
Singh, who joined Bold Care as a cofounder in 2023, has also invested in boAt and SUGAR Cosmetics, joining other celebrities entering the wellness startup space
The women's wellness market launch aligns with the growing Indian smart wearables sector, projected to see a 23.91% CAGR from 2022 to 2027
Actor Ranveer Singh-backed sexual wellness startup Bold Care has forayed into the women’s health and wellness space with the roll out of a new brand Bloom.
As per the company, Bloom will offer solutions focused on women’s health issues across various life stages. The brand’s product range includes solutions for sexual health, hygiene and period care.
“I and the founding team strongly believe in the RCM (research backed, clinically tested, maximum efficacy) methodology to provide end-to-end wellness solutions for root cause concerns women face and are excited to innovate for all phases of women’s wellness,” said Singh, who was named as Bold Care’s cofounder last year.
Founded in 2020 by Jadhav, Rahul Krishnan, Harsh Singh and Mohit Yadav, Bold Care is a D2C men’s health and wellness startup whose product portfolio includes condoms, lubes, chewables and gummies. It also sells supplements to boost hair growth, immunity, sleep, among others.
Singh’s involvement in startups extends beyond Bold Care.
In February, he invested in boAt, an audio products and smartwatch maker. Prior to that, he backed SUGAR Cosmetics in 2022.
The wellness sector has attracted other celebrities too, with PV Sindhu backing Hoop, a D2C consumer health startup, in July, and Samantha Ruth Prabhu investing in Secret Alchemist, an aromatherapy-based wellness brand, this month.
The launch of Bloom comes at a time when the Indian smart wearables market, which includes health and wellness devices, is experiencing significant growth.
According to Allied Market Research, this market is expected to register a CAGR of 23.91% over the forecast period (2022 – 2027).
